West Chester, PA, United States of America

Steve Macrides

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Steve Macrides: Innovator in Patient-Specific Immunotherapy

Introduction

Steve Macrides, an accomplished inventor based in West Chester, PA, has made significant contributions to the field of immunotherapy. With a total of five patents under his name, his work focuses on the coordination and manufacturing of cells for tailored medical treatments.

Latest Patents

One of Steve’s notable patents outlines systems and methods for coordinating the manufacturing of cells for patient-specific immunotherapy. This innovative method involves receiving a cell order request to expand a cell therapy product tailored for individual patients. It includes generating a unique patient-specific or cell order identifier associated with the request, and initiating a process to expand the cell therapy product using solid tumor samples obtained from patients. The method further addresses quality control by evaluating acceptance parameters at multiple time points during the expansion process, allowing for adjustments and rescheduling of treatment events as necessary to ensure optimal patient care.

Career Highlights

Steve has primarily worked with Iovance Biotherapeutics, Inc., a company known for its cutting-edge work in cell therapy and immunotherapy. His role involves leading innovative projects that enhance the production and effectiveness of individualized cancer treatments.

Collaborations

Throughout his career, Steve has collaborated with noteworthy colleagues such as Anne Brooks and Kristin Lanzi. Together, they have contributed to advancing the field of personalized medicine, pushing the boundaries of what is possible in patient treatment through innovative solutions and teamwork.

Conclusion

Steve Macrides exemplifies the spirit of innovation in the healthcare sector, particularly in the realm of patient-specific immunotherapy. His patents reflect a commitment to enhancing therapeutic approaches and improving patient outcomes through technological advancements. With his ongoing work and collaborations, he continues to make a profound impact on the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…